FORT LEE, N.J., April 25 /PRNewswire-FirstCall/ -- Alpharma Inc. announced that the company will release its first quarter 2006 earnings after the market close on Monday, May 1, 2006. Alpharma management will conduct a conference call / webcast on Tuesday, May 2, 2006 beginning at 8:30 AM Eastern Daylight Time to discuss its first quarter results.
The call will be open to all interested parties and may be accessed by using the following information:
CONFERENCE CALL ACCESS Domestic Dial In: (800) 374-0147 International Dial In: (706) 634-5431 Conference Call ID: 8327931
Investors can access the call in a “listen only” mode via the Internet at http://www.streetevents.com or http://www.companyboardroom.com.
In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Tuesday, May 2,, 2006 at 12:00 PM Eastern Daylight Time until Tuesday, May 9, 2006 at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com or by telephone using the following information:
REBROADCAST ACCESS Domestic Dial In: (800) 642-1687 International Dial In: (706) 645-9291 Participant Code: 8327931
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma Inc.
CONTACT: Kathleen Makrakis, VP, Investor Relations, +1-201-228-5085, orkathleen.makrakis@alpharma.com
Web site: http://www.alpharma.com/
